In 1993, the NIH published the Revitalization Act that established guidelines for minorities’ and women’s participation in clinical research. Before the 1990s, investigators largely excluded women from their research based on the 1979 guidance from the US Food and Drug Administration, or FDA. The FDA urged investigators to exclude any woman who was or could become, pregnant to protect the woman and any developing fetuses from harm. Between 1979 and 1993, several other US governmental agencies urged investigators to increase the number of women in their clinical research to improve the state of women’s healthcare. After Congress passed the National Institutes of Health Revitalization Act, hereafter Revitalization Act of 1993, investigators who used NIH funds for clinical research were required to include both women and minorities in their clinical research. The Revitalization Act established the Office of Research on Women’s Health headquartered in Washington, DC and required investigators to include women in their clinical research, thus improving the quality of women’s health research.
Details
- Title 1, Subtitle B, Parts I, II, and III of the “National Institutes of Health Revitalization Act of 1993” (1993)
- Meek, Caroline (Author)
- Dhein, Kelle (Editor)
- Arizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia. (Publisher)
- Arizona Board of Regents (Publisher)
- Law
- Legislation, Drug
- Clinical medicine--Research
- Medical research personnel
- National Institutes of Health
- NIH publication
- United States. National Institutes of Health Revitalization Act of 1993
- National Institutes of Health (U.S.). Clinical Center
- National Institutes of Health (U.S.). Office of Human Subjects Research
- Decision (United States. Government Accountability Office)
- United States. Government Accountability Office
- National Institutes of Health (U.S.). Office of Extramural Research
- National Institutes of Health (U.S.). Office for Protection from Research Risks
- drug law
- Legal
- Clinical Research